BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21843417)

  • 1. Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006.
    Zhu Y; Sorkin JD; Dwyer D; Groves C; Steinberger EK
    Prev Chronic Dis; 2011 Sep; 8(5):A114. PubMed ID: 21843417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.
    Moses KA; Zhao Z; Bi Y; Acquaye J; Holmes A; Blot WJ; Fowke JH
    Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):424-429. PubMed ID: 28695916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
    Mariotto AB; Etzioni R; Krapcho M; Feuer EJ
    Cancer; 2007 May; 109(9):1877-86. PubMed ID: 17372918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, race, and repeated prostate-specific antigen (PSA) test use in the National Health Interview Survey.
    Ross LE; Uhler RJ
    Ethn Dis; 2006; 16(1):244-7. PubMed ID: 16599378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
    Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
    Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
    Ross LE; Berkowitz Z; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and prostate cancer screening among African-American and Caucasian men.
    Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
    Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen as predictor of prostate cancer in black men and white men.
    Whittemore AS; Lele C; Friedman GD; Stamey T; Vogelman JH; Orentreich N
    J Natl Cancer Inst; 1995 Mar; 87(5):354-60. PubMed ID: 7531773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen screening among young men in the United States.
    Scales CD; Antonelli J; Curtis LH; Schulman KA; Moul JW
    Cancer; 2008 Sep; 113(6):1315-23. PubMed ID: 18696715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
    Wolf MS; Knight SJ; Lyons EA; Durazo-Arvizu R; Pickard SA; Arseven A; Arozullah A; Colella K; Ray P; Bennett CL
    Urology; 2006 Jul; 68(1):89-93. PubMed ID: 16844451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific reference ranges for serum prostate-specific antigen in black men.
    Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
    N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.
    Lacher DA; Thompson TD; Hughes JP; Saraiya M
    Adv Data; 2006 Dec; (379):1-12. PubMed ID: 17348177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in prostate cancer screening by family history.
    Drake BF; Lathan CS; Okechukwu CA; Bennett GG
    Ann Epidemiol; 2008 Jul; 18(7):579-83. PubMed ID: 18486487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.
    Spencer BA; Babey SH; Etzioni DA; Ponce NA; Brown ER; Yu H; Chawla N; Litwin MS
    Cancer; 2006 Feb; 106(4):765-74. PubMed ID: 16419068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.
    Woods VD; Montgomery SB; Herring RP; Gardner RW; Stokols D
    J Natl Med Assoc; 2006 Apr; 98(4):492-504. PubMed ID: 16623061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.